On November 12, 2025, Immatics announced updated dose escalation data from the Phase 1a clinical trial evaluating IMA401 with or without an immune checkpoint inhibitor (pembrolizumab) in heavily ...

Reports Q3 2025 GAAP Net Loss of $5.5 Million and Nine-Month Net Loss of $28.4 MillionCalculates Q3 2025 Adjusted Net Loss of $2.9 Million ...

Gold’s (XAU/USD) reversal from monthly highs near $4,250 hit last week has been contained above $4,040, but the precious ...

Anavex Life Sciences recently announced that the European Medicines Agency's Committee for Medicinal Products for Human Use delivered a negative trend vote on the Marketing Authorisation Application ...

Airbnb ( ABNB +0.71%) is a battleground stock. Either you love or hate the disruptive home-sharing platform, which went ...

D Metrology Market growth is driven by rising automation, demand for precision inspection, adoption of 3D scanning in manufacturing, automotive, and aerospace, plus expanding use in quality control ...

Marathon Digital builds an AI-driven energy platform using 1.8 GW capacity, modular centers, and MPLX–Exaion partnerships.

Japanese gross domestic product fell 1.8% in the July-September period on an annual basis, a quarterly fall of 0.4%, hit by ...

Chen Tianshi just pulled off one of the wildest wealth jumps in the tech industry, and it happened because Washington slammed ...

Nvidia (NASDAQ: NVDA) recently held its GTC conference in Washington, D.C., and CEO Jensen Huang made several big ...

Korro Bio saw its stock reach all-time lows on disappointing data for its lead pipeline candidate, while Intellia Therapeutics saw analyst downgrades on safety concerns despite releasing positive data ...

The S&P 1500 Health Care Index advanced 4.0% in the third quarter, underperforming the S&P 500, which gained 8.1%. Read more ...